Warburg Pincus has been investing in European healthcare companies for more than 20 years. During this time we have partnered with healthcare management teams across the continent including in the U.K., Germany, France, Italy, Benelux, the Nordic region and Central and Eastern Europe. Warburg Pincus has invested in leading European companies in the following sectors:
- Biotechnology
- Drug delivery
- Generic pharmaceuticals
- Healthcare services
- Medical device and medtech
- Specialty pharmaceuticals
Warburg Pincus’ current European healthcare portfolio includes: ProStrakan (London Stock Exchange: PSK LN), Eurand, Euromedic International and Archimedes Pharma.
The firm's unique, globally-integrated partnership ensures that all of our resources are committed to the success of each portfolio company. Regardless of an investment's stage of development, industry focus or geography — the right people, with the right experience, are available to every entrepreneur and management team.
